Past events

Ensuring the safety of active pharmaceutical ingredients (APIs) is of great importance. A critical aspect of this process involves the identification and mitigation of potentially mutagenic impurities, like nitrosamines. 

We were delighted to host a webinar in Japanese, titled ‘How to predict for the formation of NDSRIs’. Nitrosamine Drug Substance-Related Impurities (NDSRIs) have become a major concern in the pharmaceutical industry due to their potential to pose serious health risks to patients.

We were delighted to attend British Toxicology Society Annual Congress 2024 at Spaces at The Spine, Liverpool. The British Toxicology Society (BTS) promotes the importance and advancement of toxicology in scientific communities.

The Genetic Toxicology Association (GTA) held its annual scientific meeting April 10-12th, in Delaware, Newark. Principal Scientist, Susanne Stalford presented a poster in collaboration with Toxys, the poster is titled ‘Association of the ToxTracker® Assay to Genotoxicity Adverse Outcome Pathways’.

We were delighted to attend the 8th Impurities: Genotoxic, Nitrosamine & Beyond Summit. Senior Application Scientist, Gabriela Silveira presented ‘Accelerating nitrosamine risk assessment: Meeting emerging regulatory guidelines’.